Genyi Qu
Zhuzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Assessing the causal relationship between immune cells and prostatitis: evidence from bidirectional mendelian randomization analysis.
Journal: Mammalian genome : official journal of the International Mammalian Genome Society
Published: March 30, 2024
A multicenter study on the application of artificial intelligence radiological characteristics to predict prognosis after percutaneous nephrolithotomy.
Journal: Frontiers in endocrinology
Published: March 12, 2023
ARPC5 is transcriptionally activated by KLF4, and promotes cell migration and invasion in prostate cancer via up-regulating ADAM17 : ARPC5 serves as an oncogene in prostate cancer.
Journal: Apoptosis : an international journal on programmed cell death
Published: February 20, 2023
E2F2 serves as an essential prognostic biomarker and therapeutic target for human renal cell carcinoma by presenting "E2F2/miR-16-5p/SPTLC1" schema.
Journal: Translational oncology
Published: January 08, 2023
Prognostic prediction of clear cell renal cell carcinoma based on lipid metabolism-related lncRNA risk coefficient model.
Journal: Frontiers in genetics
Published: September 09, 2022
Prognostic Signature Development on the Basis of Macrophage Phagocytosis-Mediated Oxidative Phosphorylation in Bladder Cancer.
Journal: Oxidative medicine and cellular longevity
Published: July 02, 2022
A novel marker based on necroptosis-related long non-coding RNA for forecasting prognostic in patients with clear cell renal cell carcinoma.
Journal: Frontiers in genetics
Published: May 19, 2022
A Necroptosis-Related lncRNA to Develop a Signature to Predict the Outcome, Immune Landscape, and Chemotherapeutic Responses in Bladder Urothelial Carcinoma.
Journal: Frontiers in oncology
Published: April 25, 2022
Last Updated: 09/26/2026